NeuroPace, Inc. provided earnings guidance for the year 2024. Total revenue to range between $73 million and $77 million, representing growth of 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.39 USD | +3.08% | -4.22% | +29.87% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.87% | 385M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- NeuroPace, Inc. Provides Earnings Guidance for the Year 2024